Evaluation of satisfaction with pharmacological treatment in people with hypertension
e201910080
Keywords:
Hypertension, Patient satisfaction, Community pharmacy servicesAbstract
Background: Medication satisfaction is a patient-centered measure that helps predict the continuity of treatment, correct use and therapeutic compliance. The objective has been to evaluate the satisfaction with the treatment (ST) of subjects with arterial hypertension (HT) and find out if the type of treatment, the state of health and the personal characteristics are related to the satisfaction.
Methods: Observational cross-sectional study conducted in the community pharmacy field. A total of 484 users of antihypertensive medication were evaluated (response rate: 81.6%). The ST was evaluated through the Treatment Satisfaction with Medicines. In the statistical analysis, means comparison and correlation tests were used to verify the existence of associations between the ST level and the different variables, considering a significance level of p<0.05. Likewise, a multiple linear regression model was constructed to identify the associated variables avoiding possible confounding factors.
Results: In a range of 0-100 the mean ST value was 79.9 (SD=12.9, 95% CI= 78.8-81.0). A weak correlation was observed between perceived health score and ST (r= 0.145, p=0.001). ST was higher in subjects with controlled BP (82.1 ±12.1 SD vs 77.5 ±13.3 SD, p<0.001), in treated subjects over 5 years (83.5 ±12.8 SD vs 78.5 ±12.6 SD; p<0.001), in subjects without adverse effects (82.5 ±11.6 SD vs 68.7 ±11.9 SD; p<0.001) and in lower social classes (81.2 ±12.8 SD vs 78.5 ±12.8 SD, p=0.02). It was lower in the non-compliers with the treatment (73.2 ±12.9 vs 82.1 ±12.1, p<0.001).
Conclusions: The ST level is acceptable, despite insufficient BP control and the high rate of noncompliance. Satisfaction is conditioned both by effectiveness and by therapeutic adherence, although health status, treatment and personal characteristics also intervene.
Downloads
References
Sierra C, Ruilope LM. Effectiveness of antihypertensive treatment and control of blood pressure: Is it improvable? Med Clin (Barc). 2013;141:343–345.
Turnbull F, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527–1535.
Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandists GA, Elmer PJ et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993;270:713-724.
Mediavilla García JD, Sabio Sánchez JM, Fernández-Torres C. Tratamiento de la hipertensión arterial. Med Clin (Barc) 2003;120:108-116.
Katz JN. Patient preferences and health disparities. JAMA. 2001;286:1506-1509.
Wright JG. Evaluating the outcome of treatment. Shouldn’t We be asking patients if they are better? J Clin Epidemiol 2000;53:549-553.
Taylor TR. Understanding the choices that patients make. J Am Board Fam Pract. 2000;13:124-133.
Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12.
Revicki DA. Patient assessment of treatment satisfaction: methods and practical issues. Gut. 2004;53(Suppl IV):40–44.
Robinson A, Thomson R. Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools. Qual Health Care. 2001;10 (Suppl 1):i34-i38.
Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48-90.
Ruiz MA, Pardo A, Rejas J, Soto J, Villasante F, Aranguren JL. Development and Validation of the ‘‘Treatment Satisfaction with Medicines Questionnaire’’ (SATMED-Qs). Value Health. 2008;11:913–926.
Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costsof chronic disease in primary care patients. J Clin Epidemiol. 2008;61:1234–1240.
EuroQol group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
Grupo de trabajo de la Sociedad Española de Epidemiología y de la Sociedad Española de Medicina de Familia y Comunitaria. Una propuesta de medida de la clase social. Aten Primaria. 2000;25:350-363.
Catalá -López F, Sanfélix-Gimeno G, García-Torres C, Ridao M, Peiró S. Control of arterial hypertension in Spain: A systematic review and meta-analysis of 76 epidemiological studies on 341.632 participants. J Hypertens. 2012;30:168–176.
Sicras Mainar A, Fernández de Bobadilla J, Rejas Gutiérrez J, García Vargas M. Patrón de cumplimiento terapéutico de antihipertensivos y/o hipolipemiantes en pacientes hipertensos y/o dislipémicos en Atención Primaria. An Med Interna (Madrid). 2006;23:361-368.
Villar López J, Lizán Tudela L, Soto Alvarez J, Peiró Moreno S. Treatment satisfaction. Aten Primaria. 2009;41:637-645.
Rofail D, Abetz L, Viala M, Gait C, Baladi JF, Payne K. Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument. Value Health. 2009;12:109-117.
Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health. 2005;8(Suppl 1):S9-S24.
Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes. 2009;7:36.
Soto J. Valoración de los resultados en salud percibidos y comunicados por los pacientes: ¿necesidad o lujo? An Med Interna (Madrid). 2006;23:136–138.
Doward LC, McKenna SP. Defining patient-reported outcomes. Value Health. 2004;7(Suppl 1):S4–8.
Herdman M, Badia X. La medida de la satisfacción con el tratamiento en la Investigación de Resultados en Salud. En: Badia X, editor. La investigación en resultados en salud. Barcelona: Edimac; 2000. p. 79–93.
Lindez-Pelz S. Toward a theory of patient satisfaction. Soc Sci Med. 1982;16(5):577–82.
Kravitz RL. Patients’ expectations for medical care: an expanded formulation based on review of the literature. Med Care Res Rev. 1996;53:3–27.
Hall JA, Dornan MC. Patients sociodemographic characteristics as predictors of satisfaction with medical care: a meta-analysis. Soc Sci Med. 1990;30:811–818.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2019 Jesús López-Torres López, Gemma Blázquez Abellán, María Rosa López-Torres Hidalgo, Rosa María Milián García, Consuelo López Martínez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
